Home/Database/Dasatinib
Anti-AgingPre-clinical

Dasatinib

Dasatinib

N/A Amino Acids · MW: 488.01 Da

Amino Acids

N/A

Molecular Weight

488.01 Da

Half-life

3-5 hours

Research Score

4.6

Studies

250

Storage

Store lyophilized at -20°C, reconstituted at 2-8°C

What is Dasatinib?

Dasatinib is a clinically approved tyrosine kinase inhibitor that has become one of the best-known senolytic research compounds. In aging biology, it is studied for its ability to selectively weaken survival pathways in senescent cells.

Key Benefits & Mechanisms

senescent cell clearance

SASP reduction

tissue function support

pro-aging pathway suppression

Research Summary

Dasatinib has extensive preclinical literature as a senolytic, especially in intermittent regimens designed to avoid continuous toxicity. Studies suggest it can reduce senescent cell burden and improve age-related phenotypes in selected tissues and disease models.